CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Gift 10b5-1 | −110 | 28,697 | ||
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 33,697 |
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,435 | $90.16 | $129K | 32,262 |
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −3,177 | $91.91 | $292K | 29,085 |
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −388 | $92.90 | $36K | 28,697 |
| 2024-12-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 159,497 | ||
| 2024-12-02 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −11,349 | $92.06 | $1.0M | 453,952 |
| 2024-12-02 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,409 | $93.06 | $131K | 452,543 |
| 2024-12-02 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,242 | $94.06 | $211K | 450,301 |
| 2024-12-02 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +8,000 | $2.42 | $19K | 213,695 |
| 2024-12-02 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −5,772 | $92.07 | $531K | 207,923 |
| 2024-12-02 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,101 | $93.06 | $102K | 206,822 |
| 2024-12-02 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,127 | $94.06 | $106K | 205,695 |
| 2024-12-02 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 18,638 | ||
| 2024-11-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 117,491 |
| 2024-11-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −6,111 | $85.60 | $523K | 111,380 |
| 2024-11-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −1,757 | $86.49 | $152K | 109,623 |
| 2024-11-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −132 | $87.05 | $11K | 109,491 |
| 2024-11-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 270,827 |
Page 16 of 16 · 319 trades